Reproducibility of broth microdilution MICs for the novel siderophore cephalosporin, cefiderocol, determined using iron-depleted cation-adjusted Mueller-Hinton broth

被引:86
作者
Hackel, Meredith A. [1 ]
Tsuji, Masakatsu [2 ]
Yamano, Yoshinori [3 ]
Echols, Roger [4 ]
Karlowsky, James A. [5 ]
Sahm, Daniel F. [1 ]
机构
[1] Int Hlth Management Associates Inc, Schaumburg, IL 60173 USA
[2] Shionogi & Co Ltd, Drug Discovery & Dis Res Lab, Osaka, Japan
[3] Shionogi & Co Ltd, Pharmaceut Res Div, Osaka, Japan
[4] ID3C LLC, Clin Dev & Med Affairs, Easton, CT USA
[5] Univ Manitoba, Coll Med, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada
关键词
Cefiderocol; Siderophore; MIC; Reproducibility; Iron-depleted; Cation-adjusted Mueller-Hinton broth; Gram-negative bacilli; VITRO ANTIMICROBIAL ACTIVITY; S-649266;
D O I
10.1016/j.diagmicrobio.2019.03.003
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In 2017, the Clinical and Laboratory Standards Institute (CLSI) Subcommittee on Antimicrobial Susceptibility Testing approved the use of iron-depleted cation-adjusted Mueller-Hinton broth (ID-CAMHB) prepared with Chelex (R) 100 resin (Bio-Rad Laboratories, Hercules, CA) to determine MICs for cefiderocol. The current study examined the reproducibility of cefiderocol MICs generated for 19 clinical isolates of Gram-negative bacilli, with CAMHB produced by three manufacturers; each of the 19 isolates was tested for 10 replicates in ID-CAMHB from each manufacturer. When analyzed by individual media lot, greater than 95% of MIC results were within +/- one doubling-dilution of the mode for each of the 19 isolates tested. The remaining 5.0% of MIC results were within +/- two doubling-dilutions of the modal MIC. For all media lots combined, 92.2% of MIC results were within +/- one doubling-dilution of the modal MIC for each isolate, 99.8% were within +/- two doubling-dilutions and 100% were within three doubling-dilutions. (C) 2019 The Authors. Published by Elsevier Inc.
引用
收藏
页码:321 / 325
页数:5
相关论文
共 14 条
[1]  
Clinical and Laboratory Standards Institute (CLSI), 2016, SUBC ANT SUST TEST M
[2]  
Clinical and Laboratory StandardsInstitute (CLSI), 2017, SUBC ANT SUSC TEST M
[3]  
CLSI, 2019, 15 INF SUPPL CLIN LA
[4]   Cefiderocol MIC quality control ranges in iron-depleted cation-adjusted Mueller-Hinton broth using a CLSI M23-A4 multi-laboratory study design [J].
Huband, Michael D. ;
Ito, Akinobu ;
Tsuji, Masakatsu ;
Sader, Helio S. ;
Fedler, Kelley A. ;
Flamm, Robert K. .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 88 (02) :198-200
[5]  
Ito A, 2015, 25 EUR C CLIN MICR I
[6]   Siderophore Cephalosporin Cefiderocol Utilizes Ferric Iron Transporter Systems for Antibacterial Activity against Pseudomonas aeruginosa [J].
Ito, Akinobu ;
Nishikawa, Toru ;
Matsumoto, Shuhei ;
Yoshizawa, Hidenori ;
Sato, Takafumi ;
Nakamura, Rio ;
Tsuji, Masakatsu ;
Yamano, Yoshinori .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (12) :7396-7401
[7]   In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria [J].
Ito, Akinobu ;
Kohira, Naoki ;
Bouchillon, Samuel K. ;
West, Joshua ;
Rittenhouse, Stephen ;
Sader, Helio S. ;
Rhomberg, Paul R. ;
Jones, Ronald N. ;
Yoshizawa, Hidenori ;
Nakamura, Rio ;
Tsuji, Masakatsu ;
Yamano, Yoshinori .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (03) :670-677
[8]   Stability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases [J].
Ito-Horiyama, Tsukasa ;
Ishii, Yoshikazu ;
Ito, Akinobu ;
Sato, Takafumi ;
Nakamura, Rio ;
Fukuhara, Norio ;
Tsuji, Masakatsu ;
Yamano, Yoshinori ;
Yamaguchi, Keizo ;
Tateda, Kazuhiro .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (07) :4384-4386
[9]   In Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains [J].
Kohira, Naoki ;
West, Joshua ;
Ito, Akinobu ;
Ito-Horiyama, Tsukasa ;
Nakamura, Rio ;
Sato, Takafumi ;
Rittenhouse, Stephen ;
Tsuji, Masakatsu ;
Yamano, Yoshinori .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (02) :729-734
[10]   TRANSFERRINS AND HEME-COMPOUNDS AS IRON SOURCES FOR PATHOGENIC BACTERIA [J].
OTTO, BR ;
VERWEIJVANVUGHT, AMJJ ;
MACLAREN, DM .
CRITICAL REVIEWS IN MICROBIOLOGY, 1992, 18 (03) :217-233